Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients
Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
To assess the pharmacokinetic profile of tolvaptan in critically ill acute brain injury
patients and to secondarily evaluate the clinical response and safety of tolvaptan in acute
brain injured patients
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
Barnes-Jewish Hospital Medical University of South Carolina Otsuka America Pharmaceutical